(2S)-2-amino-3-[3,5-bis(trifluoromethyl)phenyl]propanoic acid

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (2S)-2-amino-3-[3,5-bis(trifluoromethyl)phenyl]propanoic acid
• 化学式: C₁₁H₉F₆NO₂
• 分子量: 301.18
• InChiKey: NMTMNIDBMOGRKI-QMMMGPOBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  63.3
• 氢给体数：
  2
• 氢受体数：
  9

文献信息

• Reverse-turn mimetics and composition and methods relating thereto
  申请人：Molecumetics Ltd.

  公开号：US20030220328A1

  公开（公告）日：2003-11-27

  Conformationally constrained compounds that mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins having the following structure are disclosed: 1 wherein A, R 1 , R 2 , R 2a and R 3 are as defined herein. Such compounds have utility over a wide range of fields, including use as diagnostic and therapeutic agents. In particular, compounds of this invention are useful in pharmaceutical compositions as anti-inflammatory agents as well as inhibitors of central nervous disorders. Libraries containing the compounds of this invention are also disclosed, as well as methods for screening the same to identify biologically active members.

  本发明揭示了限制构象的化合物，其模仿具有以下结构的生物活性肽和蛋白质的反向转向区域的二级结构：1其中A，R1，R2，R2a和R3的定义如本文所述。此类化合物在广泛领域内具有实用性，包括用作诊断和治疗剂。特别地，本发明的化合物可用作制药组合物中的抗炎剂以及中枢神经系统疾病的抑制剂。本发明还揭示了含有该化合物的文库，以及筛选该文库以识别生物活性成员的方法。
• Reverse-turn mimetics and compositions and methods related thereto
  申请人：Nagula Gangadhar

  公开号：US20050245528A1

  公开（公告）日：2005-11-03

  Conformationally constrained compounds that mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins having the following structure are disclosed: wherein A, R 1 , R 2 , R 2a and R 3 are as defined herein. Such compounds have utility over a wide range of fields, including use as diagnostic and therapeutic agents. In particular, compounds of this invention are useful in pharmaceutical compositions as anti-inflammatory agents as well as inhibitors of central nervous disorders. Libraries containing the compounds of this invention are also disclosed, as well as methods for screening the same to identify biologically active members.

  本发明揭示了限制构象的化合物，其模拟具有以下结构的生物活性肽和蛋白质的反转区域的二级结构： 其中A、R1、R2、R2a和R3如本文所定义。这些化合物在广泛的领域中具有实用性，包括用作诊断和治疗剂。特别是，本发明的化合物在制药组合物中作为抗炎剂以及中枢神经障碍的抑制剂方面具有用途。本发明还揭示了包含该化合物的库，以及筛选这些库以识别生物活性成员的方法。
• SILYLALKYLOXYARYL COMPOUNDS AND METHODS FOR TREATING CANCER
  申请人：THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE

  公开号：US20160159832A1

  公开（公告）日：2016-06-09

  Silylalkyloxyaryl compounds useful as anti-cancer agents. The compounds and pharmaceutical compositions containing them are particularly useful for the treatment of melanoma, colon, neuroblastoma, bladder, breast, lung, pancreatic, melanoma, sarcoma, lymphoma or gastric cancer.

  Silylalkyloxyaryl化合物可用作抗癌剂。这些化合物和含有它们的制药组合物特别适用于黑色素瘤、结肠癌、神经母细胞瘤、膀胱癌、乳腺癌、肺癌、胰腺癌、黑色素瘤、肉瘤、淋巴瘤或胃癌的治疗。
• Reverse-turn mimetics and compositions and methods relating thereto
  申请人：Qabar N. Maher

  公开号：US20050250780A1

  公开（公告）日：2005-11-10

  Reverse-turn mimetics and methods relating to the same having the following structure are disclosed: including pharmaceutically acceptable salts and stereoisomers thereof, wherein R 1 , R 2 , R 3 and R 4 are as defined herein. Such compounds have utility over a wide range of applications, including use as diagnostic and therapeutic agents. In particular, compounds of this invention, and pharmaceutical compositions containing such compounds, are neurokinin (tachykinin) antagonists. Libraries containing the reverse-turn mimetics of this invention are also disclosed.

  本发明公开了具有以下结构的反向旋转拟态化合物及其相关方法： 包括其药学上可接受的盐和立体异构体，其中 R 1 , R 2 , R 3 和 R 4 如本文所定义。此类化合物具有广泛的用途，包括用作诊断和治疗药物。特别是，本发明的化合物和含有此类化合物的药物组合物是神经激肽（速激肽）拮抗剂。此外，还公开了含有本发明反向旋转模拟物的化合物库。
• Process for preparing alpha-carboxamide derivatives
  申请人：Convergence Pharmaceuticals Limited

  公开号：EP2477964B1

  公开（公告）日：2015-02-11